Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Research Support, N.I.H., Extramural

Comparative Study

Research Support, U.S. Gov't, P.H.S.

Research Support, U.S. Gov't, Non-P.H.S.

Clinical Trial, Phase II

Retracted Publication

Randomized Controlled Trial

Multicenter Study

Publication Year

From

Quick links

Individual year

2025

2022

2021

2019

2017

2016

2015

2013

2012

2011

2010

2009

2007

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Cyclin E""[mesh_terms]

28 Results

Searching titles within these results

E- and A-type cyclins as markers for cancer diagnosis and prognosis.

Amber Yasmeen, Wolfgang E Berdel, Hubert Serve, Carsten Müller-Tidow

Expert review of molecular diagnostics 2004;3(5):617-33

Full Text

Abstract

Mutual antagonism between Hippo signaling and cyclin E drives intracellular pattern formation.

Yu-Yang Jiang, Wolfgang Maier, Uzoamaka N Chukka, Michael Choromanski, Chinkyu Lee, Ewa Joachimiak, Dorota Wloga, Wayland Yeung, Natarajan Kannan, Joseph Frankel, Jacek Gaertig

The Journal of cell biology 2021;219(9):e202002077

Free Full Text

Abstract

Variability in the timing of G(1)/S transition.

G Chiorino, M Lupi

Mathematical biosciences 2002;177-178():85-101

Full Text

Abstract

Patterns of cyclin E, retinoblastoma protein, and p21Cip1/WAF1 immunostaining in the oncogenesis of papillary thyroid carcinoma.

Jan Brzeziński, Adam Migodziński, Aleksandra Toczek, Józef Tazbir, Marek Dedecjus

Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1037-43

Full Text

Abstract

Low-molecular-weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer.

Kelly K Hunt, Mi Li, Spiridon Tsavachidis, Fuchenchu Wang, Tuyen Bui, Tuyen Duong Thanh Nguyen, Linjie Luo, Asha S Multani, Melissa L Bondy, Khandan Keyomarsi

Oncogene 2022;41(50):5331-5346

Free Full Text

Abstract

Immunohistochemical expression of cell-cycle regulators in pediatric embryonal brain tumors.

Maria Moschovi, George A Alexiou, Amalia Patereli, George Siozos, George Sfakianos, Neofytos Prodromou, Kalliopi Stefanaki

Journal of neuro-oncology 2013;109(3):529-34

Full Text

Abstract

Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines.

Bharat B Aggarwal, Sanjeev Banerjee, Uddalak Bharadwaj, Bokyung Sung, Shishir Shishodia, Gautam Sethi

Biochemical pharmacology 2007;73(7):1024-32

Full Text

Abstract

γ-Sitosterol from Acacia nilotica L. induces G2/M cell cycle arrest and apoptosis through c-Myc suppression in MCF-7 and A549 cells.

Shenbagamoorthy Sundarraj, Ramar Thangam, Vellingiri Sreevani, Krishnasamy Kaveri, Palani Gunasekaran, Shanmugam Achiraman, Soundarapandian Kannan

Journal of ethnopharmacology 2012;141(3):803-9

Full Text

Abstract

Pervasive chromosomal instability and karyotype order in tumour evolution.

Thomas B K Watkins, Emilia L Lim, Marina Petkovic, Sergi Elizalde, Nicolai J Birkbak, Gareth A Wilson, David A Moore, Eva Grönroos, Andrew Rowan, Sally M Dewhurst, Jonas Demeulemeester, Stefan C Dentro, Stuart Horswell, Lewis Au, Kerstin Haase, Mickael Escudero, Rachel Rosenthal, Maise Al Bakir, Hang Xu, Kevin Litchfield, Wei Ting Lu, Thanos P Mourikis, Michelle Dietzen, Lavinia Spain, George D Cresswell, Dhruva Biswas, Philippe Lamy, Iver Nordentoft, Katja Harbst, Francesc Castro-Giner, Lucy R Yates, Franco Caramia, Fanny Jaulin, Cécile Vicier, Ian P M Tomlinson, Priscilla K Brastianos, Raymond J Cho, Boris C Bastian, Lars Dyrskjøt, Göran B Jönsson, Peter Savas, Sherene Loi, Peter J Campbell, Fabrice Andre, Nicholas M Luscombe, Neeltje Steeghs, Vivianne C G Tjan-Heijnen, Zoltan Szallasi, Samra Turajlic, Mariam Jamal-Hanjani, Peter Van Loo, Samuel F Bakhoum, Roland F Schwarz, Nicholas McGranahan, Charles Swanton

Nature 2021;587(7832):126-132

Free Full Text

Abstract

Resveratrol inhibits cell cycle progression in U937 cells.

Laura Castello, Luciana Tessitore

Oncology reports 2005;13(1):133-7

Full Text

Abstract

Naturally- and experimentally-designed restorations of the Parkin gene deficit in autosomal recessive juvenile parkinsonism.

Hirohide Asai, Makito Hirano, Takao Kiriyama, Masanori Ikeda, Satoshi Ueno

Biochemical and biophysical research communications 2010;391(1):800-5

Full Text

Abstract

Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer.

Marie Ahnström Waltersson, Marie Stenmark Askmalm, Bo Nordenskjöld, Tommy Fornander, Lambert Skoog, Olle Stål

International journal of oncology 2009;34(2):441-8

Full Text

Abstract

Insights on Structural Characteristics and Ligand Binding Mechanisms of CDK2.

Yan Li, Jingxiao Zhang, Weimin Gao, Lilei Zhang, Yanqiu Pan, Shuwei Zhang, Yonghua Wang

International journal of molecular sciences 2016;16(5):9314-40

Free Full Text

Abstract

Neferine, an alkaloid ingredient in lotus seed embryo, inhibits proliferation of human osteosarcoma cells by promoting p38 MAPK-mediated p21 stabilization.

Xiyu Zhang, Zhaojian Liu, Bing Xu, Zhaoliang Sun, Yaoqin Gong, Changshun Shao

European journal of pharmacology 2012;677(1-3):47-54

Full Text

Abstract

Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.

Alexandre A B A da Costa, Luisa M do Canto, Simon Jonas Larsen, Adriana Regina Gonçalves Ribeiro, Carlos Eduardo Stecca, Annabeth Høgh Petersen, Mads M Aagaard, Louise de Brot, Jan Baumbach, Glauco Baiocchi, Maria Isabel Achatz, Silvia Regina Rogatto

BMC cancer 2019;19(1):422

Free Full Text

Abstract

Results: 1 – 15 / 28

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Cyclin E""[mesh_terms]

E- and A-type cyclins as markers for cancer diagnosis and prognosis.

Mutual antagonism between Hippo signaling and cyclin E drives intracellular pattern formation.

Variability in the timing of G(1)/S transition.

Patterns of cyclin E, retinoblastoma protein, and p21Cip1/WAF1 immunostaining in the oncogenesis of papillary thyroid carcinoma.

Low-molecular-weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer.

Immunohistochemical expression of cell-cycle regulators in pediatric embryonal brain tumors.

Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines.

γ-Sitosterol from Acacia nilotica L. induces G2/M cell cycle arrest and apoptosis through c-Myc suppression in MCF-7 and A549 cells.

Pervasive chromosomal instability and karyotype order in tumour evolution.

Resveratrol inhibits cell cycle progression in U937 cells.

Naturally- and experimentally-designed restorations of the Parkin gene deficit in autosomal recessive juvenile parkinsonism.

Altered expression of cyclin E and the retinoblastoma protein influences the effect of adjuvant therapy in breast cancer.

Insights on Structural Characteristics and Ligand Binding Mechanisms of CDK2.

Neferine, an alkaloid ingredient in lotus seed embryo, inhibits proliferation of human osteosarcoma cells by promoting p38 MAPK-mediated p21 stabilization.

Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.

Results for
""Cyclin E""[mesh_terms]